MAP3K11 and breast cancer: In summary, we have shown that a novel, brain penetrant MLK3 inhibitor (URMC099) can reduce the migratory activity of breast cancer cells and normal breast epithelial cells in an in vitro scratch wound healing assay and an in vitro transwell migration assay.